If you are disciplined, lean, and looking for a small edge, it may offer incremental benefit
the physician bills the E/M only Step 10: Submit a Clean Claim Scrub for missing NDC, missing J-code, missing modifier, and incorrect POS before submission Verify the claim against payer-specific requirements, which vary by contract Submit and track for payment within the payer's expected adjudication window CPT code 96372 billing guidelines require accurate alignment of the administration code, the drug code, the diagnosis code, and the modifier on every single claim line
Overlapping stability windows: All three peptides demonstrate stability at pH 5.5-7.0, and bacteriostatic water is formulated at pH 5.7
FDA-Approved vs Research Compounds Understanding the distinction between FDA-approved peptides and research-only compounds is essential for evaluating safety: Category Examples Evidence Base Regulation FDA-Approved Semaglutide (Ozempic), Teriparatide (Forteo), Tesamorelin (Egrifta) Phase I-III clinical trials, post-market surveillance Prescription required, manufactured under cGMP Previously Approved Sermorelin (Geref withdrawn 2008) Clinical trial data exists, but product no longer marketed Research use only (currently) Research Only BPC-157, TB-500, Ipamorelin, KPV Preclinical data (varying depth), no completed human trials Sold for laboratory research, not human consumption For the complete list of FDA-approved peptides and their indications, see our FDA Approved Peptides List 2026 guide
